Disclosures for "VGL101: An Immunotherapy that Enhances Microglial Survival for Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)"
-
Ms. Larson has nothing to disclose.
-
Mr. Gergits has received personal compensation for serving as an employee of Vigil Neuroscience.
-
Dr. Renoux has received personal compensation for serving as an employee of Vigil Neuroscience. An immediate family member of Dr. Renoux has received personal compensation for serving as an employee of Amylyx Pharmaceuticals.
-
-
Dr. Tchessalova has nothing to disclose.
-
Mr. Dejanovic has received personal compensation for serving as an employee of Vigil Neuroscience.
-
Dr. Thackaberry has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Thackaberry has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Samsara Biocapital. Dr. Thackaberry has stock in Vigil Neurosciences.
-
Prof. Colonna has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cell Signaling Technology. Prof. Colonna has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vigil Neuroscience. Prof. Colonna has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NGMBio. Prof. Colonna has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aclaris. Prof. Colonna has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cancer Immunology Research. Prof. Colonna has stock in Vigil Neuroscience. The institution of Prof. Colonna has received research support from Vigil Neuroscience. The institution of Prof. Colonna has received research support from Kyowa-Kirin. The institution of Prof. Colonna has received research support from NGMBio.
-
Mr. Gray has received personal compensation for serving as an employee of Inscopix, Inc. Mr. Gray has received personal compensation for serving as an employee of Vigil Neuroscience, Inc.. Mr. Gray has stock in Cerevel Therapeutics.
-
Dr. Mirescu has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Mirescu has stock in Vigil Neuroscience.